Raptor Pharma Cystinosis Drug Meets Late-Stage Trial Goal

Raptor Pharmaceutical announced its late-stage clinical trial of its investigational drug delayed release Cysteamine, for the treatment of nephropathic cystinosis, met the primary endpoint.
RTTNews